Government Notices and Health Approvals




14 MARCH 2013

NEW ZEALAND GAZETTE, No. 31

Notice

  1. Title and commencement—(1) This notice may be cited as the Resource Management (Approval of KiwiRail Holdings Limited as a Requiring Authority) Notice 2013.

(2) This notice shall come into force on the 7th day after its publication in the New Zealand Gazette.

  1. Approval as a requiring authority—KiwiRail Holdings Limited is hereby approved as a requiring authority under section 167 of the Resource Management Act 1991, for its network utility operation being the construction, operation, maintenance, replacement, upgrading, improvement and extension of its railway line.

  2. Revocation—This notice revokes the Resource Management (Approval of the New Zealand Railways Corporation as Requiring Authority) Notice 2004 (dated the 16th day of September 2004 and published in the New Zealand Gazette, 23 September 2004, No. 124, page 3070).

Dated at Wellington this 4th day of March 2013.

HON AMY ADAMS, Minister for the Environment.

go1447


Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Enbrel
Active Ingredient: Etanercept 25mg
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany

Product: Enbrel
Active Ingredient: Etanercept 50mg
Dosage Form: Powder for injection with diluent
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany

Product: Enbrel
Active Ingredient: Etanercept 25mg
Dosage Form: Solution for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers:

  • Vetter Pharma-Fertigung GmbH & Co Kg, Langenargen, Germany
  • Pfizer Ireland Pharmaceuticals, Dublin, Ireland
  • Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany

Product: Enbrel
Active Ingredient: Etanercept 50mg
Dosage Form: Solution for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers:

  • Vetter Pharma-Fertigung GmbH & Co Kg, Langenargen, Germany
  • Pfizer Ireland Pharmaceuticals, Dublin, Ireland
  • Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany

Dated this 7th day of March 2013.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1516

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2013, No 31





✨ LLM interpretation of page content

🏗️ Resource Management (Approval of KiwiRail Holdings Limited as Requiring Authority) Notice 2013 (continued from previous page)

🏗️ Infrastructure & Public Works
4 March 2013
Resource Management, KiwiRail, Requiring Authority
  • HON AMY ADAMS, Minister for the Environment

🏥 Consent to the Distribution of New Medicines (Enbrel)

🏥 Health & Social Welfare
7 March 2013
Medicines, Distribution, Enbrel, Etanercept
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health